(Q40682439)

22 September 2017

Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease (English)

1 reference

22 September 2017

0 references

Castaño EM

1

1 reference

22 September 2017

Prelli F

series ordinal

2

1 reference

22 September 2017

Pras M

series ordinal

3

1 reference

22 September 2017

Frangione B

series ordinal

4

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 July 1995

1 reference

Journal of Biological Chemistry

22 September 2017

1 reference

22 September 2017

270

1 reference

22 September 2017

29

1 reference

22 September 2017

17610-17615

1 reference

Immunodetection of the amyloid P component in Alzheimer's disease.

22 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer's disease and AA, AL, senile cardiac and medullary carcinoma-associated amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

SP-40,40 is a constituent of Alzheimer's amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

The amino acid sequence of neuritic plaque amyloid from a familial Alzheimer's disease patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

The characterization of soluble amyloid prepared in water

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Characterization of high molecular weight amyloid A proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Is Alzheimer's disease an apolipoprotein E amyloidosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Abnormal in vivo metabolism of apolipoprotein E4 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Variant apolipoprotein AI as a major constituent of a human hereditary amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Regulation of apolipoprotein E gene expression after injury of the rat sciatic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

On the association between amyloid fibrils and glycosaminoglycans; possible interactive role of Ca2+ and amyloid P-component

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.29.17610

21 January 2018

Identifiers

DOI

10.1074/JBC.270.29.17610

1 reference

release_uwasii37abgxth7kp5x5sxix2y

22 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uwasii37abgxth7kp5x5sxix2y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference